At ValuraNova, we are not just a company; we are a beacon of expertise in the realm of Medical Aesthetics recruitment on a global scale. With a profound understanding of the nuances and complexities of the industry, we specialize in connecting exceptional talent with leading organisations worldwide. Our dedication to excellence is unwavering, as evidenced by our track record of placing candidates in 20 countries across the globe. Led by a team of seasoned professionals, we bring a consultative approach to every partnership, ensuring that candidates and clients alike find their perfect match. Our journey is deeply rooted in the expertise and heritage of our sister business, Guided Solutions. Guided Solutions has been a pioneer in global executive search within the medical technology sector for over two decades and is at the forefront of helping ground-breaking MedTech companies in sourcing and securing the highest calibre talent in the industry. Building upon this foundation, ValuraNova is its specialised arm devoted exclusively to the dynamic field of Medical Aesthetics. At ValuraNova, we don’t just connect candidates with opportunities; we sculpt enduring partnerships.
| Website | https://www.valuranova.com |
| Employees | 9 (9 on RocketReach) |
| Founded | 2024 |
| Industry | Staffing and Recruiting |
| Keywords | Medical Professionals, Aesthetic Professionals, Aesthetic Recruitment, Healthcare Recruitment, Medical Staffing, Cosmetics Recruitment, Medical Jobs, Spa Recruitment, Aesthetic Jobs, Permanent Healthcare Roles, Permanent Medical Roles, Clinical Recruitment, Global Recruitment, Physician Recruitment, Executive Search, Medical Headhunting, Healthcare Headhunting |
| Competitors | Scholastic, Amplify, Lexia Learning, Khan Academy, Carnegie Learning, NoRedInk, Edgenuity Inc. (now Imagine Learning), DreamBox Learning, Edmodo, i-Ready +45 more (view full list) |
Looking for a particular ValuraNova employee's phone or email?
Kristien Esser is the Founder and CEO of ValuraNova.
9 people are employed at ValuraNova.